Citizens Reiterates Market Outperform Rating on Opus Genetics, Keeps $17 Target
Citizens reiterated its Market Outperform rating and $17.00 price target on Opus Genetics. The target implies 319.8% upside from the stock’s October 15 close of $4.05.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.